<VariationArchive RecordType="classified" VariationID="1320145" VariationName="NM_006306.4(SMC1A):c.109+575dup" VariationType="Duplication" Accession="VCV001320145" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-11-11" MostRecentSubmission="2021-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1310390" VariationID="1320145">
      <GeneList>
        <Gene Symbol="SMC1A" FullName="structural maintenance of chromosomes 1A" GeneID="8243" HGNC_ID="HGNC:11111" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53374149" stop="53422728" display_start="53374149" display_stop="53422728" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53401069" stop="53449617" display_start="53401069" display_stop="53449617" Strand="-" />
          </Location>
          <OMIM>300040</OMIM>
          <Haploinsufficiency last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006306.4(SMC1A):c.109+575dup</Name>
      <CanonicalSPDI>NC_000023.11:53421916:GGGG:GGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53421916" stop="53421917" display_start="53421916" display_stop="53421917" variantLength="1" positionVCF="53421916" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53448866" stop="53448867" display_start="53448866" display_stop="53448867" variantLength="1" positionVCF="53448866" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>T8fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.53448870dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.53448870dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.53421920dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.53421920dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_006988.2" sequenceAccession="NG_006988" sequenceVersion="2" change="g.5754dup">
            <Expression>NG_006988.2:g.5754dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033076.2" sequenceAccession="NG_033076" sequenceVersion="2" change="g.4066dup">
            <Expression>NG_033076.2:g.4066dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281463.1" sequenceAccession="NM_001281463" sequenceVersion="1" change="c.21dup">
            <Expression>NM_001281463.1:c.21dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001268392.1" sequenceAccession="NP_001268392" sequenceVersion="1" change="p.Thr8fs">
            <Expression>NP_001268392.1:p.Thr8fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006306.4" sequenceAccession="NM_006306" sequenceVersion="4" change="c.109+575dup" MANESelect="true">
            <Expression>NM_006306.4:c.109+575dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_773" sequenceAccession="LRG_773">
            <Expression>LRG_773:g.5754dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_773t1" sequenceAccession="LRG_773t1">
            <Expression>LRG_773t1:c.21dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_773p1" sequenceAccession="LRG_773p1" change="p.Thr8fs">
            <Expression>LRG_773p1:p.Thr8fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2075758478" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006306.4(SMC1A):c.109+575dup AND Congenital muscular hypertrophy-cerebral syndrome" Accession="RCV001775318" Version="1">
        <ClassifiedConditionList TraitSetID="3183">
          <ClassifiedCondition DB="MedGen" ID="C1802395">Congenital muscular hypertrophy-cerebral syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-11" MostRecentSubmission="2021-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3183" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4850" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cornelia de Lange syndrome 2</ElementValue>
                <XRef ID="MONDO:0010370" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital muscular hypertrophy-cerebral syndrome</ElementValue>
                <XRef ID="Congenital+muscular+hypertrophy-cerebral+syndrome/8077" DB="Genetic Alliance" />
                <XRef ID="55016009" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS2</ElementValue>
                <XRef Type="MIM" ID="300590" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15259" />
                <XRef ID="15259" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C1802395" DB="MedGen" />
              <XRef ID="MONDO:0010370" DB="MONDO" />
              <XRef Type="MIM" ID="300590" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3950441" SubmissionDate="2021-11-05" DateLastUpdated="2021-11-11" DateCreated="2021-11-11">
        <ClinVarSubmissionID localKey="X-53448866-T-TG" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002012101" DateUpdated="2021-11-11" DateCreated="2021-11-11" Type="SCV" Version="1" SubmitterName="3billion" OrgID="507830" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). Patient's phenotype is considered compatible with Cornelia de Lange syndrome 2 (3billion dataset, PP4). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq</NamePlatform>
              <TypePlatform>whole exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001249" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMC1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001281463.1:c.21dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300590" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10606558</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3950441" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001249" MappingRef="HP">
        <MedGen CUI="C3714756" Name="Intellectual disability" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950441" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950441" TraitType="Disease" MappingType="XRef" MappingValue="300590" MappingRef="OMIM">
        <MedGen CUI="C1802395" Name="Congenital muscular hypertrophy-cerebral syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3950441" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

